Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fennobon is a Finnish pharmaceutical company specializing in the development and manufacture of throat lozenges, medical devices, and food supplements. Based in Ylöjärvi, the company operates a specialized GMP-certified production facility dedicated to solid dosage forms, particularly lozenges. Fennobon produces its own proprietary brands, such as the Fennobon antiseptic lozenge line, while also providing contract manufacturing (CMO) services for global pharmaceutical partners. Their product portfolio focuses on oral health and respiratory relief, utilizing active ingredients like chlorhexidine and lidocaine to treat sore throats and oral infections. The company is recognized as a leading Nordic specialist in lozenge technology and sugar-free formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fennobon.